Transchromix LLC

Chapel Hill, NC

UEI
F4MEAAM4J6F7
CAGE
7HG66
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
102 San Juan Dr, Chapel Hill, NC 27514, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Transchromix LLC's 3 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Targeting novel translation mechanism to treat nfoo-induced hypoxia-related brain injuries - project summary opioid… Grant · R41DA064241 National Institute on Drug Abuse $399,994
Novel brain-penetrant drugs for translation-targeting therapeutics of alzheimer's disease - abstract alzheimer's disease… Grant · R41AG085859 National Institute on Aging $994,436
Novel therapeutic intervention of early-stage T1D - abstract type 1 diabetes (T1D) is a chronic autoimmune disease in… Grant · R41DK133051 National Institute of Diabetes and Digestive and Kidney Diseases $601,340

Quick answers

What is Transchromix LLC's UEI?

Transchromix LLC's Unique Entity ID (UEI) in SAM.gov is F4MEAAM4J6F7.

What is Transchromix LLC's CAGE code?

Transchromix LLC's CAGE code is 7HG66.

What is Transchromix LLC's primary NAICS code?

Transchromix LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Transchromix LLC located?

Transchromix LLC's physical address in SAM.gov is 102 San Juan Dr, Chapel Hill, NC 27514, USA.

Is Transchromix LLC registered in SAM.gov?

Yes. Transchromix LLC's SAM.gov registration is active through May 8, 2027.

What is Transchromix LLC's most recent federal award?

Transchromix LLC's most recent federal grant award is Targeting novel translation mechanism to treat nfoo-induced hypoxia-related brain injuries - project summary opioid… (R41DA064241), from National Institute on Drug Abuse, on July 1, 2026.

On GovTribe

See Transchromix LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login